» Articles » PMID: 26227005

Length of Optic Nerve Double Inversion Recovery Hypersignal is Associated with Retinal Axonal Loss

Overview
Journal Mult Scler
Publisher Sage Publications
Specialty Neurology
Date 2015 Aug 1
PMID 26227005
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To assess the association between optic nerve double inversion recovery (DIR) hypersignal length and retinal axonal loss in neuroinflammatory diseases affecting optic nerves.

Methods: We recruited patients previously affected (> 6 months) by a clinical episode of optic neuritis (ON). We had 25 multiple sclerosis (MS) patients, eight neuromyelitis optica spectrum disorder (NMOSD) patients and two patients suffering from idiopathic caused ON undergo brain magnetic resonance imaging (MRI); including a 3-dimensional (3D) DIR sequence, optical coherence tomography (OCT) examination and visual disability evaluation. Evaluation criteria were retinal thickness/volume, optic nerve DIR hypersignal length and high/low contrast vision acuity.

Results: In the whole cohort, we found good associations (< 0.0001) between optic nerve DIR hypersignal length, peripapillary retinal nerve fiber layer thickness, inner macular layers volumes, and visual disability. We found subclinical radiological optic nerve involvement in 38.5% of non-ON MS eyes.

Conclusions: Optic nerve DIR hypersignal length may be a biomarker for retinal axonal loss, easily applicable in routine and research on new anti-inflammatory or neuroprotective drug evaluation. Detection of subclinical ON with 3D-DIR in a non-negligible proportion of MS patients argues in favor of optic nerve imaging in future OCT MS studies, in order to achieve a better understanding of retinal axonal loss in non-ON eyes.

Citing Articles

Improving criteria for dissemination in space in multiple sclerosis by including additional regions.

Foster M, Pontillo G, Davagnanam I, Collorone S, Prados F, Kanber B Ann Clin Transl Neurol. 2024; 11(10):2572-2582.

PMID: 39078773 PMC: 11514922. DOI: 10.1002/acn3.52170.


Retinal optical coherence tomography measures in multiple sclerosis: a systematic review and meta-analysis.

El Ayoubi N, Ismail A, Fahd F, Younes L, Chakra N, Khoury S Ann Clin Transl Neurol. 2024; 11(9):2236-2253.

PMID: 39073308 PMC: 11537126. DOI: 10.1002/acn3.52165.


Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management: A MAGNIMS Position Paper and Future Perspectives.

Sastre-Garriga J, Vidal-Jordana A, Toosy A, Enzinger C, Granziera C, Frederiksen J Neurology. 2024; 103(3):e209677.

PMID: 39018513 PMC: 11271394. DOI: 10.1212/WNL.0000000000209677.


How far should I manage acute optic neuritis as an ophthalmologist? A United Kingdom perspective.

Laviers H, Petzold A, Braithwaite T Eye (Lond). 2024; 38(12):2238-2245.

PMID: 38867071 PMC: 11306244. DOI: 10.1038/s41433-024-03164-4.


Association of plasma sPD-1 and sPD-L1 with disease status and future relapse in AQP4-IgG (+) NMOSD.

Liu J, Shao X, Fan J, Wang Y, Cao Y, Tan G Ann Clin Transl Neurol. 2023; 11(2):436-449.

PMID: 38069466 PMC: 10863926. DOI: 10.1002/acn3.51964.